Balanced Crystalloid vs. Saline in Children With Septic Shock
Multiple Electrolyte Solution vs. Saline in Pediatric Septic Shock
1 other identifier
interventional
708
1 country
4
Brief Summary
Fluid resuscitation is the cornerstone of pediatric shock management; current practices of fluid resuscitation in children are not evidence based. Normal saline is the preferred crystalloid recommended during initial resuscitation in shock, as the incidence of hyponatremia is lower with normal saline compared to all other fluids available and commonly used. However, normal saline has its own set of undesired physicochemical actions. Emerging data strongly indicate the increased incidence of hyperchloremia, metabolic acidosis and consequently, acute kidney injury associated with infusion of large volumes of normal saline. Balanced salt solutions or crystalloids, which have composition resembling plasma but lower chloride concentrations than normal saline, clearly decrease the risk of hyperchloremia and metabolic acidosis in adult as well as pediatric studies when used during the peri-operative period. The results favored balanced solutions in comparison to normal saline. Recent systematic reviews comparing balanced or buffered versus non-buffered fluids for surgery in adults favored the former solution as the metabolic derangements were less with the use of this type of fluid. In adult patients, the two solutions have been compared in various other settings as well such as in traumatic brain injury and in shock. The results favored balanced solutions in comparison to normal saline. However, in the non-surgical setting there is a paucity of evidence on the use of these solutions in children with shock and more evidence needs to be generated to support or refute the use of this fluid as compared to normal saline. Given this background, the investigators decided to compare the effect of two solutions on the incidence of acute kidney injury in children resuscitated with either of the two fluids. Children receiving at least one fluid bolus at 20 ml/kg in the first hour would be enrolled and followed up for the proposed outcome variables. The investigators plan to enroll 708 patients over a period of 3 years. The investigators believe that the proposed study will provide answer to the research question of which of the fluids could be preferred for resuscitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2017
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 1, 2016
CompletedFirst Posted
Study publicly available on registry
July 15, 2016
CompletedStudy Start
First participant enrolled
April 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2020
CompletedDecember 21, 2021
December 1, 2021
2.8 years
March 1, 2016
December 6, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
New or progressive acute kidney injury defined as increase in serum creatinine by > 0.3mg/dL within 48 hours or to 1.5 times baseline or more within the last 7 days or urine output less than 0.5 mL/kg/h for 6 hours
Incidence of new or progressive AKI in first 7 days after randomization/ intervention
From the time of randomization/intervention to 7 days of admission
Secondary Outcomes (8)
Proportion of patients with serum chloride levels > 108 meq/L at admission, 6, 24, 48 and 72 hours
At 6, 24, 48 and 72 hours after randomization
Number of fluid boluses received in the first 6 hours after randomization
From the time of randomization to 6 hours
Total fluids received in the first 24 hours, 24-48 hours and 48-72hrs in ml/kg after randomization
From the time of randomization to 72 hours
Mortality (serious adverse event)
From the time of randomization till death or discharge from ICU, whichever came first assessed upto 100 days
Time to resolution of AKI
From the time of onset of AKI after randomization till death or discharge from hospital, whichever came first assessed upto 100 days
- +3 more secondary outcomes
Other Outcomes (3)
Safety outcome 1
From the time of randomization/intervention to 7 days of admission
Safety outcome 2
From the time of randomization/intervention to mortality
Safety outcome 3
From the time of initiating the bolus to its completion
Study Arms (2)
Balanced crystalloid or multiple electrolyte solution group
EXPERIMENTALAfter enrollment, a fluid bolus comprising of 'multiple electrolyte solution (Plasma-Lyte P)' solution at a dose of 20 ml/kg over 15-20 minutes (recommended) with careful monitoring for features of fluid overload would be administered to each child. Fluid resuscitation will be targeted at achieving the therapeutic end points as given in study definitions. After this the management protocol will be as per recommendations of the American College of Critical Care Medicine 2017 for septic shock in children.
0.9% saline or saline group
ACTIVE COMPARATORAfter enrollment, a fluid bolus comprising of 'saline' solution at a dose of 20 ml/kg over 15-20 minutes (recommended) with careful monitoring for features of fluid overload would be administered to each child. Fluid resuscitation will be targeted at achieving the therapeutic end points as given in study definitions. After this the management protocol will be as per recommendations of the American College of Critical Care Medicine 2017 for septic shock in children.
Interventions
Multiple electrolyte solution as boluses would be administered.
saline as boluses would be administered
Eligibility Criteria
You may qualify if:
- Children 2 month to ≤ 15 years with features of septic shock - defined as children who have a suspected infection manifested by hypothermia or hyperthermia and have at least two clinical signs of decreased perfusion with or without hypotension
You may not qualify if:
- Children receiving fluid boluses before enrollment
- Children with cardiogenic shock
- Known patient with chronic kidney disease with baseline deranged renal function (eGFR \< 90 ml/1.73 m2/min)
- Severe malnutrition
- Children whose parents refuse to give an informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
St Johns Medical College and Hospital
Bengaluru, Karnataka, 560034, India
All India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, 110029, India
PGIMER
Chandigarh, India
JIPMER
Puducherry, 605006, India
Related Publications (1)
Sankar J, Muralidharan J, Lalitha AV, Rameshkumar R, Pathak M, Das RR, Nadkarni VM, Ismail J, Subramanian M, Nallasamy K, Dev N, Kumar UV, Kumar K, Sharma T, Jaravta K, Thakur N, Aggarwal P, Jat KR, Kabra SK, Lodha R. Multiple Electrolytes Solution Versus Saline as Bolus Fluid for Resuscitation in Pediatric Septic Shock: A Multicenter Randomized Clinical Trial. Crit Care Med. 2023 Nov 1;51(11):1449-1460. doi: 10.1097/CCM.0000000000005952. Epub 2023 Jun 9.
PMID: 37294145DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jhuma Sankar, MD Ped
All India Institute of Medical Sciences
- STUDY CHAIR
Sushil K Kabra, MD Ped
All India Institute of Medical Sciences
- STUDY DIRECTOR
Rakesh Lodha, MD Ped
All India Institute of Medical Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Serially numbered, sealed, opaque pouches containing 10 bags of 500 ml of either MES or saline each will be kept at the study site. Each of the 500 ml bags will be packed in sealed opaque covers inside the pouches as well.The research staff will pick the bag of fluids kept as per allocation sequence and start the bolus in the patient.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Additional Professor Pediatrics
Study Record Dates
First Submitted
March 1, 2016
First Posted
July 15, 2016
Study Start
April 1, 2017
Primary Completion
January 15, 2020
Study Completion
January 15, 2020
Last Updated
December 21, 2021
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share
Individual patient data will not be shared